Sign Out
Patients with known hypersensitivity to ACE inhibitor or any component of the formulation.
Patients with a history of angioedema related to ACE inhibitor therapy and those with hereditary or and those with hereditary or idiopathic angioedema.
Patients with diabetes mellitus concomitant use with aliskiren.
Coadministration with or within 36 hours of switching to or from a neprilysin inhibitor (e.g. sacubitril).
